West Pharmaceutical Services Inc (WST) stock
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3031% above fair value
$404.02−10.10 (-2.44%)
Close on Nov 18, 2026Market cap $28.14BP/E 45.3Yield 0.21%
West Pharmaceutical Services revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
West Pharmaceutical Services's revenue for the twelve months ending Sep 30, 2026 was $3.40B, up 12.6% year over year. For fiscal 2025 it was $3.07B, up 6.3% from the year before. Over ten years it grew 8.2% a year on average. The highest annual figure on record is $3.07B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.07B | +6.3% |
| FY2024 | Dec 31, 2024 | $2.89B | -1.9% |
| FY2023 | Dec 31, 2023 | $2.95B | +2.2% |
| FY2022 | Dec 31, 2022 | $2.89B | +2.0% |
| FY2021 | Dec 31, 2021 | $2.83B | +31.9% |
| FY2020 | Dec 31, 2020 | $2.15B | +16.7% |
| FY2019 | Dec 31, 2019 | $1.84B | +7.1% |
| FY2018 | Dec 31, 2018 | $1.72B | +7.4% |
| FY2017 | Dec 31, 2017 | $1.60B | +6.0% |
| FY2016 | Dec 31, 2016 | $1.51B | +7.8% |
| FY2015 | Dec 31, 2015 | $1.40B | -1.5% |
| FY2014 | Dec 31, 2014 | $1.42B | +3.9% |
| FY2013 | Dec 31, 2013 | $1.37B | +8.1% |
| FY2012 | Dec 31, 2012 | $1.27B | +6.2% |
| FY2011 | Dec 31, 2011 | $1.19B | +7.9% |
| FY2010 | Dec 31, 2010 | $1.10B | +4.6% |
| FY2009 | Dec 31, 2009 | $1.06B | +0.4% |
| FY2008 | Dec 31, 2008 | $1.05B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $874.50M | +8.7% |
| Q2 FY2026 | Jun 30, 2026 | $872.30M | +13.8% |
| Q1 FY2026 | Mar 31, 2026 | $844.90M | +21.0% |
| Q4 FY2025 | Dec 31, 2025 | $805.00M | +7.5% |
| Q3 FY2025 | Sep 30, 2025 | $804.60M | +7.7% |
| Q2 FY2025 | Jun 30, 2025 | $766.50M | +9.2% |
| Q1 FY2025 | Mar 31, 2025 | $698.00M | +0.4% |
| Q4 FY2024 | Dec 31, 2024 | $748.80M | +2.3% |
| Q3 FY2024 | Sep 30, 2024 | $746.90M | -0.1% |
| Q2 FY2024 | Jun 30, 2024 | $702.10M | -6.9% |
| Q1 FY2024 | Mar 31, 2024 | $695.40M | -3.0% |
| Q4 FY2023 | Dec 31, 2023 | $732.00M | +3.3% |
| Q3 FY2023 | Sep 30, 2023 | $747.40M | +8.8% |
| Q2 FY2023 | Jun 30, 2023 | $753.80M | -2.3% |
| Q1 FY2023 | Mar 31, 2023 | $716.60M | -0.5% |
| Q4 FY2022 | Dec 31, 2022 | $708.70M | -3.0% |
| Q3 FY2022 | Sep 30, 2022 | $686.90M | -2.8% |
| Q2 FY2022 | Jun 30, 2022 | $771.30M | +6.6% |
| Q1 FY2022 | Mar 31, 2022 | $720.00M | +7.4% |
| Q4 FY2021 | Dec 31, 2021 | $730.80M | +26.0% |
| Q3 FY2021 | Sep 30, 2021 | $706.50M | +28.9% |
| Q2 FY2021 | Jun 30, 2021 | $723.60M | +37.3% |
| Q1 FY2021 | Mar 31, 2021 | $670.70M | +36.5% |
| Q4 FY2020 | Dec 31, 2020 | $580.20M | +23.3% |
| Q3 FY2020 | Sep 30, 2020 | $548.00M | +20.1% |
| Q2 FY2020 | Jun 30, 2020 | $527.20M | +12.2% |
| Q1 FY2020 | Mar 31, 2020 | $491.50M | +10.8% |
| Q4 FY2019 | Dec 31, 2019 | $470.60M | +11.4% |
| Q3 FY2019 | Sep 30, 2019 | $456.10M | +5.7% |
| Q2 FY2019 | Jun 30, 2019 | $469.70M | +5.0% |
| Q1 FY2019 | Mar 31, 2019 | $443.50M | +6.7% |
| Q4 FY2018 | Dec 31, 2018 | $422.50M | +1.7% |
| Q3 FY2018 | Sep 30, 2018 | $431.70M | +8.4% |
| Q2 FY2018 | Jun 30, 2018 | $447.50M | +12.6% |
| Q1 FY2018 | Mar 31, 2018 | $415.70M | +7.2% |
| Q4 FY2017 | Dec 31, 2017 | $415.60M | +8.7% |
| Q3 FY2017 | Sep 30, 2017 | $398.20M | – |
| Q2 FY2017 | Jun 30, 2017 | $397.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $387.70M | – |
| Q4 FY2016 | Dec 31, 2016 | $382.30M | – |
See a number that looks wrong?